NORTHCOTT JOHN 4
4 · NEKTAR THERAPEUTICS · Filed Dec 4, 2019
Insider Transaction Report
Form 4
NORTHCOTT JOHN
SVP & Chief Commercial Officer
Transactions
- Award
Common Stock
2019-12-02+200,000→ 200,000 total - Award
Stock Option
2019-12-02+200,000→ 200,000 totalExercise: $19.48Exp: 2027-12-01→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The grant of Restricted Stock Units ("RSUs") will vest according to a four-year vesting schedule, with 25% vesting on February 15, 2021 and the remainder vesting over three years in equal quarterly installments.
- [F2]This option vests as to 25% of the shares subject to the option on the first anniversary of the grant date and the remaining 75% of the shares subject to the option vest in equal monthly installments over the three-year period thereafter, in each case based on the Reporting Person's continuous service to the issuer.